LDS/Medical Tests/Phospholipid (Cardiolipin) Antibody, IgM

Phospholipid (Cardiolipin) Antibody, IgM

Cardiolipins are phospholipids that play a vital role in cellular function such as osmosis and the transfer of metabolites across the plasma membrane. They also allow for components of the phospholipids such as phosphatidylserine to be transferred to the surface of the cell which is the first stage of blood clotting. Autoantibodies to cardiolipin can be produced by the immune system and they are the most common antiphospholipid autoantibody. This immune response is not well understood and the cause is often difficult to determine. When antibodies to these cardiolipins are present, they are unable to function properly and disease can develop. Anticardiolipins are seen in various disease states such as Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS). Anti-cardiolipin antibodies when present can cause many signs and symptoms such as vascular thrombosis, thrombocytopenia, and hemolytic anemia. They are also implicated in recurrent miscarriages, premature birth, and preeclampsia. Although autoimmune response is most often the cause of anti-cardiolipin antibodies, they may be caused by other factors that only temporarily cause an immune response such as certain drugs, cancer or infections. The assays for cardiolipin antibodies frequently detect and quantitate IgG, IgM, and IgA antibodies. Most anti-phospholipid antibodies are IgG or IgM.

The anticardiolipin antibodies actually detect proteins that are noncovalently bound to the phospholipid as well as the lipids themselves; the best characterized protein is beta 2 glycoprotein 1 and most assays detect this in addition to the cardiolipin. Antiphospholipid antibody assay is not the same as lupus anticoagulant assay. The lupus anticoagulant assay is a functional clotting assay that depends on the presence of phospholipid for clotting. Anti-phospholipid antibodies prolong this clotting time in vitro and these antibodies are commonly referred to as lupus anticoagulant antibodies. Only anti-phospholipid antibodies that can cross-link beta 2 glycoprotein 1 can prolong clotting, so not all anti-phospholipid antibodies possess lupus anticoagulant activity.

Criteria exist to diagnose and/or rule out Antiphospholipid Syndrome (APS). One laboratory value (e.g., positive titer) and one clinical symptom (e.g., thrombosis) must be present to diagnose APS. Other findings of APS that can be present but are not used in the diagnosis include thrombocytopenia, nephropathy, and neurological symptoms.

  • As an aid in diagnosis of blood clotting disorders
  • Aids in the diagnosis of Antiphospholipid Syndrome (APS)
  • As an aid in diagnosis of autoimmune disorders such as SLE
  • As an aid in diagnosis of cardiovascular disorders related to thrombosis
  • As an aid in determining the cause of recurrent miscarriage and other pregnancy complications
  • The test may be ordered in a patient with a positive VDRL test since that test uses phospholipds and may be falsely positive in patients with anti-cardiolipin antibody

Increased in:

  • Antiphospholipid Syndrome
  • Systemic Lupus Erythematosus
  • HIV infection
  • Thrombocytopenia
  • Recurrent miscarriages
  • Premature labor
  • Preeclampsia
  • Some drugs
  • Vascular thrombosis
  • Hemolytic anemia

<20 MPL (Negative)

 

 

 

Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

Serum (SST) or Plasma Citrate (Light Blue).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Anti-cardiolipin profile that includes IgM, IgG, an IgA, CBC, Comprehensive Metabolic Panel, ANA, Antiphospholipid antibody, Prothrombin time, Factor V Leiden, Factor II Prothrombin Mutation, Lupus Anticoagulant, Anti-Beta 2 Glycoprotein, IgG, Protein C antigen and activity, Protein S antigen and activity.
1-3 days, often same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Hematol Oncol Clin North Am. 2008 Feb;22(1):19-32. [PMID: 18207063]
  • J Thromb Thrombolysis. 2001 Sep;12(1):89-93. [PMID: 11711694]
  • Lupus. 2004;13(9):649-52. [PMID: 15485095]
  • Haemostasis. 1994 May-Jun;24(3):165-74. [PMID: 7988946]
  • Ann Intern Med. 990 May 1;112(9):682-98. [PMID: 2110431]
  • Phospholipid Antibodies. In Mayo Interpretive Handbook (pp. 625-626). Rochester: Mayo Medical Laboratories (2009).